Cite

    Galluzzo, M., D'Adamio, S., Silvaggio, D., Lombardo, P., Bianchi, L., & Talamonti, M. (2020). in which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis. Expert opinion on biological therapy, 20, 173–182. http://access.bl.uk/ark:/81055/vdc_100099951035.0x00003c